187 related articles for article (PubMed ID: 23988756)
1. Semiautomated volumetric measurement on postcontrast MR imaging for analysis of recurrent and residual disease in glioblastoma multiforme.
Chow DS; Qi J; Guo X; Miloushev VZ; Iwamoto FM; Bruce JN; Lassman AB; Schwartz LH; Lignelli A; Zhao B; Filippi CG
AJNR Am J Neuroradiol; 2014 Mar; 35(3):498-503. PubMed ID: 23988756
[TBL] [Abstract][Full Text] [Related]
2. A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma.
Kanaly CW; Mehta AI; Ding D; Hoang JK; Kranz PG; Herndon JE; Coan A; Crocker I; Waller AF; Friedman AH; Reardon DA; Sampson JH
J Neurosurg; 2014 Sep; 121(3):536-42. PubMed ID: 25036205
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trial.
Gahrmann R; van den Bent M; van der Holt B; Vernhout RM; Taal W; Vos M; de Groot JC; Beerepoot LV; Buter J; Flach ZH; Hanse M; Jasperse B; Smits M
Neuro Oncol; 2017 Jun; 19(6):853-861. PubMed ID: 28204639
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study.
De Barros A; Attal J; Roques M; Nicolau J; Sol JC; Charni S; Cohen-Jonathan-Moyal E; Roux FE
Clin Neurol Neurosurg; 2020 Sep; 196():105972. PubMed ID: 32512407
[TBL] [Abstract][Full Text] [Related]
5. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
[TBL] [Abstract][Full Text] [Related]
6. Fully Automated Enhanced Tumor Compartmentalization: Man vs. Machine Reloaded.
Porz N; Habegger S; Meier R; Verma R; Jilch A; Fichtner J; Knecht U; Radina C; Schucht P; Beck J; Raabe A; Slotboom J; Reyes M; Wiest R
PLoS One; 2016; 11(11):e0165302. PubMed ID: 27806121
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.
Kuhnt D; Becker A; Ganslandt O; Bauer M; Buchfelder M; Nimsky C
Neuro Oncol; 2011 Dec; 13(12):1339-48. PubMed ID: 21914639
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial.
Schmainda KM; Prah MA; Zhang Z; Snyder BS; Rand SD; Jensen TR; Barboriak DP; Boxerman JL
AJNR Am J Neuroradiol; 2019 Jul; 40(7):1132-1139. PubMed ID: 31248863
[TBL] [Abstract][Full Text] [Related]
9. Automatic estimation of extent of resection and residual tumor volume of patients with glioblastoma.
Meier R; Porz N; Knecht U; Loosli T; Schucht P; Beck J; Slotboom J; Wiest R; Reyes M
J Neurosurg; 2017 Oct; 127(4):798-806. PubMed ID: 28059651
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
[No Abstract] [Full Text] [Related]
11. Automated and Semiautomated Segmentation of Rectal Tumor Volumes on Diffusion-Weighted MRI: Can It Replace Manual Volumetry?
van Heeswijk MM; Lambregts DM; van Griethuysen JJ; Oei S; Rao SX; de Graaff CA; Vliegen RF; Beets GL; Papanikolaou N; Beets-Tan RG
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):824-31. PubMed ID: 26972655
[TBL] [Abstract][Full Text] [Related]
12. Multi-modal glioblastoma segmentation: man versus machine.
Porz N; Bauer S; Pica A; Schucht P; Beck J; Verma RK; Slotboom J; Reyes M; Wiest R
PLoS One; 2014; 9(5):e96873. PubMed ID: 24804720
[TBL] [Abstract][Full Text] [Related]
13. Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastoma.
Auer TA; Della Seta M; Collettini F; Chapiro J; Zschaeck S; Ghadjar P; Badakhshi H; Florange J; Hamm B; Budach V; Kaul D
Acta Radiol; 2021 Sep; 62(9):1200-1207. PubMed ID: 32938221
[TBL] [Abstract][Full Text] [Related]
14. Tumor Response Assessment in Diffuse Intrinsic Pontine Glioma: Comparison of Semiautomated Volumetric, Semiautomated Linear, and Manual Linear Tumor Measurement Strategies.
Gilligan LA; DeWire-Schottmiller MD; Fouladi M; DeBlank P; Leach JL
AJNR Am J Neuroradiol; 2020 May; 41(5):866-873. PubMed ID: 32354716
[TBL] [Abstract][Full Text] [Related]
15. Volumetric and MGMT parameters in glioblastoma patients: survival analysis.
Iliadis G; Kotoula V; Chatzisotiriou A; Televantou D; Eleftheraki AG; Lambaki S; Misailidou D; Selviaridis P; Fountzilas G
BMC Cancer; 2012 Jan; 12():3. PubMed ID: 22214427
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
[TBL] [Abstract][Full Text] [Related]
17. Automated Volumetric Analysis of Postoperative Magnetic Resonance Imaging Predicts Survival in Patients with Glioblastoma.
Krivoshapkin AL; Sergeev GS; Gaytan AS; Kalneus LE; Kurbatov VP; Abdullaev OA; Salim N; Bulanov DV; Simonovich AE
World Neurosurg; 2019 Jun; 126():e1510-e1517. PubMed ID: 30910753
[TBL] [Abstract][Full Text] [Related]
18. MRI assessment of relapsed glioblastoma during treatment with bevacizumab: volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression--a pilot study.
Pichler J; Pachinger C; Pelz M; Kleiser R
Eur J Radiol; 2013 May; 82(5):e240-5. PubMed ID: 23399039
[TBL] [Abstract][Full Text] [Related]
19. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
Ellingson BM; Aftab DT; Schwab GM; Hessel C; Harris RJ; Woodworth DC; Leu K; Chakhoyan A; Raymond C; Drappatz J; de Groot J; Prados MD; Reardon DA; Schiff D; Chamberlain M; Mikkelsen T; Desjardins A; Holland J; Ping J; Weitzman R; Wen PY; Cloughesy TF
Neuro Oncol; 2018 Sep; 20(10):1411-1418. PubMed ID: 29660005
[TBL] [Abstract][Full Text] [Related]
20. Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.
Huang RY; Rahman R; Hamdan A; Kane C; Chen C; Norden AD; Reardon DA; Mukundun S; Wen PY
Cancer; 2013 Oct; 119(19):3479-88. PubMed ID: 23821555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]